Quantitative Investment Management LLC Purchases New Shares in Equifax, Inc. $EFX

Key Points

• Quantitative Investment Management LLC has acquired 11,634 shares of Equifax, Inc., valued at approximately $2.83 million, as per their recent SEC disclosure.
• Equifax reported better-than-expected earnings for the quarter, with an EPS of $2.00 surpassing the consensus estimate of $1.92, and revenue reaching $1.54 billion, a year-over-year increase of 7.4%.
• The company declared a quarterly dividend of $0.50 per share, representing a yield of 0.8%, with the payment date set for September 15.

Quantitative Investment Management LLC acquired a new position in shares of Equifax, Inc. (NYSE:EFX - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 11,634 shares of the credit services provider's stock, valued at approximately $2,833,000.

Other hedge funds have also recently modified their holdings of the company. Brighton Jones LLC boosted its position in Equifax by 49.2% in the fourth quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider's stock worth $927,000 after purchasing an additional 1,200 shares during the last quarter. Guggenheim Capital LLC raised its position in Equifax by 17.9% in the fourth quarter. Guggenheim Capital LLC now owns 1,998 shares of the credit services provider's stock worth $509,000 after acquiring an additional 303 shares during the period. First Trust Advisors LP purchased a new position in Equifax in the fourth quarter valued at about $23,057,000. Dark Forest Capital Management LP grew its position in shares of Equifax by 4.7% during the 4th quarter. Dark Forest Capital Management LP now owns 1,628 shares of the credit services provider's stock valued at $415,000 after acquiring an additional 73 shares during the period. Finally, Kovitz Investment Group Partners LLC increased its stake in shares of Equifax by 22.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,900 shares of the credit services provider's stock worth $2,268,000 after purchasing an additional 1,631 shares during the last quarter. Institutional investors own 96.20% of the company's stock.

Equifax Trading Down 1.3%

NYSE:EFX traded down $3.20 during trading hours on Tuesday, reaching $247.56. The company's stock had a trading volume of 749,834 shares, compared to its average volume of 1,055,440. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.77 and a current ratio of 0.77. The firm has a market capitalization of $30.65 billion, a price-to-earnings ratio of 48.45, a PEG ratio of 3.02 and a beta of 1.64. The firm has a 50-day simple moving average of $252.15 and a 200-day simple moving average of $250.27. Equifax, Inc. has a 1 year low of $199.98 and a 1 year high of $309.63.

Equifax (NYSE:EFX - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The credit services provider reported $2.00 EPS for the quarter, topping the consensus estimate of $1.92 by $0.08. Equifax had a return on equity of 18.89% and a net margin of 10.95%.The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the previous year, the business earned $1.82 earnings per share. The company's quarterly revenue was up 7.4% on a year-over-year basis. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. Research analysts expect that Equifax, Inc. will post 7.58 EPS for the current fiscal year.

Equifax Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd will be issued a $0.50 dividend. The ex-dividend date is Tuesday, September 2nd. This represents a $2.00 annualized dividend and a dividend yield of 0.8%. Equifax's dividend payout ratio (DPR) is currently 39.14%.

Analyst Ratings Changes

EFX has been the subject of several research reports. UBS Group reduced their price objective on Equifax from $315.00 to $278.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Robert W. Baird cut their price target on Equifax from $310.00 to $289.00 and set an "outperform" rating for the company in a research note on Wednesday, July 23rd. Wells Fargo & Company lowered their price objective on Equifax from $310.00 to $300.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 23rd. BMO Capital Markets dropped their price objective on shares of Equifax from $280.00 to $260.00 and set a "market perform" rating on the stock in a report on Wednesday, July 23rd. Finally, Oppenheimer reduced their target price on shares of Equifax from $296.00 to $279.00 and set an "outperform" rating for the company in a research note on Wednesday, July 23rd. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, Equifax currently has an average rating of "Moderate Buy" and an average price target of $283.53.

Insider Activity at Equifax

In related news, CEO Mark W. Begor sold 48,264 shares of the company's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $241.71, for a total transaction of $11,665,891.44. Following the completion of the sale, the chief executive officer directly owned 142,872 shares in the company, valued at $34,533,591.12. This represents a 25.25% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.40% of the stock is currently owned by insiders.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.